Article info
Clinical science
Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion
- Correspondence to Yoshinori Mitamura, Department of Ophthalmology, Institute of Biomedical Sciences, Tokushima University Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan; ymitaymitaymita{at}yahoo.co.jp
Citation
Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion
Publication history
- Received March 2, 2020
- Revised April 26, 2020
- Accepted June 8, 2020
- First published July 3, 2020.
Online issue publication
April 22, 2021
Article Versions
- Previous version (22 April 2021).
- Previous version (22 April 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.